Interleukin‐17 and interleukin‐22 promote tumor progression in human nonmelanoma skin cancerLavinia Nardinocchi(Istituto Dermopatico dell'Immacolata), Andrea Cavani(Istituto Dermopatico dell'Immacolata)European Journal of ImmunologyDecember 9, 201410.1002/eji.201445052Cited by 96SaveCiteExport RISWatch citationsRelated PapersHIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation|Aging|2011|51Targeting Hypoxia in Cancer Cells by Restoring Homeodomain Interacting Protein-Kinase 2 and p53 Activity and Suppressing HIF-1α|PLoS ONE|2009|49Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma|Biomedicines|2021|4